Skip to main content

Table 1 Baseline characteristics of patients enrolled in the Pathway CH-1 study [8]

From: Cost-effectiveness of stimulation of the sphenopalatine ganglion (SPG) for the treatment of chronic cluster headache: a model-based analysis based on the Pathway CH-1 study

Variable

Pathway CH-1 (N = 28)

Age (years)

45 (20–63)

Male gender (no.; %)

27 (84 %)

Baseline CH attacks per day

2.74 (0.57–10)